This company seems to have been delisted
Reason: Acquired by Johnson & Johnson
Last recorded trade on: August 1, 2024
Source: https://www.jnj.com/media-center/press-releases/johnson-johnson-completes-acquisition-of-abiomed
Reason: Acquired by Johnson & Johnson
Last recorded trade on: August 1, 2024
Source: https://www.jnj.com/media-center/press-releases/johnson-johnson-completes-acquisition-of-abiomed
Abiomed
ABMD
A$583.30
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Categories
Abiomed is an American medical devices company that develops and manufactures the circulatory support device Impella, the world’s smallest heart pump.
Abiomed (ABMD) - Cash on Hand
Cash on Hand as of September 2022 : A$1.25 Billion
According to Abiomed's latest financial reports the company has A$1.25 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Abiomed - Cash on Hand chart (from 2013 to 2022)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-03-31 | A$1.01 B | 31.74% |
| 2021-03-31 | A$0.76 B | 6.45% |
| 2020-03-31 | A$0.72 B | 4.46% |
| 2019-03-31 | A$0.69 B | 46.59% |
| 2018-03-31 | A$0.47 B | 56.78% |
| 2017-03-31 | A$0.30 B | 8.78% |
| 2016-03-31 | A$0.27 B | 59.52% |
| 2015-03-31 | A$0.17 B | 109.77% |
| 2014-03-31 | A$82.62 M | 12.15% |
| 2013-03-31 | A$73.66 M | -0.97% |
| 2012-03-31 | A$74.39 M | 27.47% |
| 2011-03-31 | A$58.36 M | -7.78% |
| 2010-03-31 | A$63.28 M | -22.63% |
| 2009-03-31 | A$81.8 M | 96.72% |
| 2008-03-31 | A$41.58 M | -55.28% |
| 2007-03-31 | A$92.98 M | 112.84% |
| 2006-03-31 | A$43.68 M | -18.66% |
| 2005-03-31 | A$53.71 M | 48.1% |
| 2004-03-31 | A$36.26 M | -59.82% |
| 2003-03-31 | A$90.25 M | -32.48% |
| 2002-03-31 | A$0.13 B | -30.16% |
| 2001-03-31 | A$0.19 B | 8.57% |
| 2000-03-31 | A$0.17 B | 514.55% |
| 1999-03-31 | A$28.68 M | -28.14% |
| 1998-03-31 | A$39.91 M | 234.31% |
| 1997-03-31 | A$11.94 M | -12.08% |
| 1996-03-31 | A$13.58 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Teleflex TFX | A$0.43 B | -65.37% | 🇺🇸 USA |
 Boston Scientific BSX | A$1.10 B | -11.63% | 🇺🇸 USA |
 AtriCure ATRC | A$0.15 B | -87.82% | 🇺🇸 USA |